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Abstract
Background: Sini-San (SNS) is a formulation of four Traditional Chinese Drugs that exhibits beneficial therapeutic
effects in liver injury and hepatitis. However, there are no reports describing its effects on the hepatitis B X-protein
(HBx)-induced invasion and metastasis in hepatoma cells, and the detailed molecular mechanisms of its actions are
still unclear.
Methods: In this study, we investigated the mechanisms underlying SNS-mediated inhibition of HBx-induced cell
invasion and the inhibition of secreted and cytosolic MMP-9 production, using gelatin zymography and Western
blot analysis in a human hepatoma cell line (HepG2). Relative luciferase activity was assessed for MMP-9, NF-κB, or
AP-1 reporter plasmid-transfected cells.
Results: SNS suppressed MMP-9 transcription by inhibiting activator protein (AP)-1 and nuclear factor-κ B (NF-κB)
activity. SNS suppressed HBx-induced AP-1 activity through inhibition of phosphorylation in the extracellular
signal-related kinase (ERK) and c-Jun N-terminal kinase (JNK) signaling pathways. SNS also suppressed
HBx-induced inhibition of NF-κB nuclear translocation through IκB and suppressed HBx-induced activation of ERK/
phosphatidylinositol 3-kinase/Akt upstream of NF-κB and AP-1.
Conclusions: SNS suppresses the invasiveness and metastatic potential of hepatocellular carcinoma cells by
inhibiting multiple signal transduction pathways.
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Background
The hepatitis B virus (HBV) is associated with hepatitis
and the development of liver cirrhosis, non-
compensated liver disorder, and hepatocellular carcin-
oma (HCC) [1–3]. HBV genomic DNA comprises 4
partially-overlapping open-reading frames encoding core
antigen, polymerase, and X protein [4]. Of these 4 HBV
proteins, the X protein (HBx) has been implicated in the
development of HCC [5–7]. HBx promotes tumor cell
invasion and is involved in tumor metastasis and the re-
currence of HCC [8–10]. Several studies have demon-
strated that HBx affects the invasive ability of HCC
through indirect activation of matrix metalloproteinases
(MMPs) [8, 9, 11]. MMPs mediate extracellular matrix
remodeling and are involved in a variety of pathophysio-
logical processes, including tumor metastasis [12]. In
HCC, an increased level of MMP-9 is associated with
vascular invasion [13]. Several mechanisms have been
proposed to explain the pro-oncogenic role of HBx, in-
cluding activation of signal transduction cascades and
transcription factors and interaction with a variety of
cellular proteins [14–16]. The promoter region of MMP-
9 has binding sites for the transcription factors AP-1
and NF-κB [17]. Stimulators, such as cytokines, control
the expression of MMP-9 by modulating the activation
of AP-1 and NF-κB through Ras/Raf/ERK, JNK, and PI-
3 K-AKT/PKB signaling pathways [9, 14, 18, 19].
Many traditional medicines and phytochemicals have
been considered as potential therapeutic candidates for
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controlling the invasiveness and metastasis of HCC
[20–25]. Sini-San (SNS) comprises four prescriptions of
Traditional Chinese Medicine (TCM) used in the treat-
ment of various types of liver disease. This formulation
was first described in “Treatise on Cold-induced Febrile
Diseases (Shanghan Lun),” written by the famous Chinese
physician Zhang Zhongjing (150 to 219 A.D. in the
Chinese Eastern Han Dynasty). SNS has been used clin-
ically routinely and has produced beneficial effects on
liver injury [26, 27], hepatitis [28], chronic stress model
[29], and Palmoplantar hidrosis [30]. The formulation
shows both hepatoprotective activity and a virus clear-
ing effect in patients with hepatitis [28]. Previous study
showed SNS significantly inhibited tumor growth in
HepG2 xenograft model [31]. However, the mecha-
nisms for this effect are unclear. The aim of this study
was to explore the mechanism underlying the inhibitory
effect of SNS on HBx-induced cellular invasion and
MMP-9 expression. In this study, we demonstrated that
the inhibition of HBx-induced MMP-9 activity by SNS
in hepatoma cells occurs via NF-κB and AP-1 signaling.
Methods
Extract of Sini-San (SNS)
Koda Pharmaceutics Ltd. (Taoyuan, Taiwan, ROC) pro-
vided the medicinal plants used to prepare SNS. Four
raw herbs, Chaihu (Radix Bupleuri Chinensis), Baishao
(Radix Paeoniae Alba), Zhishi (Fructus Aurantii Imma-
turus), and Gancao (Radix Glycyrrhizae) were employed
at a ratio of 1:1:1:1. The procedure used to prepare the
SNS decoction for this study is according to the method
Koda Pharmaceutics Ltd. optimized. Briefly, raw mate-
rials from the four plants named above were combined
to achieve a total weight of 100 g. Distilled water
(100 ml) was added and the mixture was boiled for 2 h.
After the volume was reconstituted to 100 ml with dis-
tilled water, the liquid was separated from the herbs and
set aside. An additional 100 ml of distilled water was
added to the herbs, and the 2 h boiling process was re-
peated. The volume was reconstituted to 100 ml, and
the liquid was separated from the herbs and combined
with the first water extract to achieve a final volume of
200 ml. The combined extracts were then filtered to re-
move particulate matter. This preparation (final concen-
tration of 0.5 g/ml) was assigned a batch number of
32146903. For in vitro use, the herbal extract (SNS) was
centrifuged at 7500 rpm for 30 min, and the supernatant
was retained. A filtration through a 0.2-mm filter
(Microgen, Laguna Hills, CA, USA) was performed to
sterilize the preparation, which was then lyophilized and
stored at −20 °C. The lyophilized product was reconsti-
tuted in methanol to a final concentration of 1 g/ml. To
ensure the purity of SNS extract and to control the
variation of quality for each batch, high performance li-
quid chromatography (HPLC) was performed.
Reagents
For analysis of the signaling pathways involved in HBx-
induced DNA-binding of AP-1 and NF-κB, we also
treated HepG2-HBx cells with the p38 inhibitor
SB203580 (SB), the MEK/ERK inhibitor PD98059 (PD),
the JNK inhibitor JNKI, the IKK inhibitor BMS, and the
Akt1/2 kinase inhibitor AKTI (Sigma-Aldrich) to block
these pathways.
Cell culture
The human hepatoma cell line HepG2 (Bioresource Col-
lection and Research Centre, Taiwan) was maintained in
Dulbecco modified Eagle medium (DMEM) (Life Tech-
nologies, Gaithersburg, MD, USA) and supplemented
with 10 % fetal bovine serum (FBS) (HyClone, Logan,
UT, USA). HepG2 cells were cultured in 25 cm2 flasks at
37 °C. The flasks were immediately capped and sealed
with parafilm to minimize evaporation.
MTT assay
Cell growth was measured using a modified MTT assay.
Hepatoma cells were resuspended in medium (100 μL)
in 96-well plates and cultured with or without DOX and
SNS. After incubation for 24 h, MTT (20 μL) was added
to each well and incubated further at 37 °C for 4 h. The
supernatant was removed and DMSO (200 μL) was
added to each well to solubilize the formazan product.
The absorbance was measured at 470 nm using a micro-
plate reader (Sigma). PT67, a retrovirus packaging cell
line, was grown in Dulbecco’s modified Eagle’s medium
supplemented with 10 % fetal calf serum, penicillin G
(50 units/mL), streptomycin (50 μg/mL), and fungizone
(1.25 μg/mL) at 37 °C in a 5 % CO2 incubator. HepG2
stable transfectants (HepG2-HBx) with doxycycline
(DOX)-inducible expression of HBx-GFP were generated
and cultured in complete MEM medium supplemented
with 100 μg/mL G418 and 50 μg/mL hygromycin. The
viability of variously treated HepG2-HBx cells was deter-
mined by MTT assay.
Transfection and retrovirus infection
To investigate the relationship between HBx and MMP-
9 expression, the vector pRT-HBxGFP was constructed
and provided by Shin-Lian Doong [32]. DNAs were in-
troduced into cells through transfection or retrovirus in-
fection. Transfection was performed using the calcium
phosphate DNA precipitation method according to the
procedure described by Chen et al. [33]. The cells were
transiently transfected with 5 μg of plasmid DNA of
MMP9-Luc using SuperFect Transfection Reagent
(Qiagen, Valencia, CA, USA). For retrovirus infection,
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media was collected from virus-producing PT67 cells and
filtered through a 0.45-μm membrane. After addition of
polybrene to a final concentration of 0.4 μg/mL, the whole
mixture was poured onto the target cells. After incubation
for 16 h, the virus-containing medium was aspirated. Cells
were washed and incubated for 2 additional days before
they were ready for selection or analysis.
Wound-healing assay
HepG2-HBx cell lines were grown to 90 % confluence
in 6-well plates at 37 °C in a 5 % CO2 incubator. A
wound was created by scratching the cell monolayer
with a sterile 200 μL pipette tip. The cells were then
washed twice with PBS to remove floating cells, and
serum-free medium was added. Photomicrographs of
the wound were obtained at 100 × magnification.
Invasion assay
Cell invasion was measured using Matrigel-coated film
inserts (pore size, 8-μm) fitted into 24-well invasion
chambers (Becton-Dickinson Bioscience, Franklin Lakes,
NJ, USA). HepG2-HBx cells (5 × 104 cells) were sus-
pended in DMEM (200 μL) and added to the upper
compartment of an invasion chamber in the presence
or absence of DOX. DMEM (500 μL) was added to the
lower chamber. The chambers were incubated at 37 °C
in 5 % CO2. After 24 h, the filter inserts were removed,
and the cells on the upper surfaces of the filters were
removed with cotton swabs. Cells on the lower sur-
faces were stained with crystal violet, and the number
of cells was determined by microscopy. Final values
were calculated as the average of the total number of
cells from 3 filters.
Zymography
Gelatin zymography was used to determine the expres-
sion and activity of MMP-9 in HBx-treated human
hepatoma cells in the presence or absence of SNS.
HepG2-HBx cells were seeded onto 100 mm plates
using serum-free medium and pretreated with DOX.
SNS was added in different concentrations and incu-
bated for 24 h. Conditioned medium was collected, and
protein concentrations were determined using the Bio-
Rad protein assay (Bio-Rad, Hercules, CA, USA). Cul-
ture supernatants were subjected to electrophoresis on
gelatin substrate gels (10 % SDS-polyacrylamide gels
containing 1 mg/mL of gelatin). The gels were treated
with 2.5 % Triton X-100 for 30 min and incubated at
37 °C for 24 h in a buffer containing 100 mM Tris–HCl
(pH 7.4), 0.15 M NaCl, and 15 mM CaCl2. The gels
were stained with Coomassie Blue R-250 and then de-
stained with water until clear zones appeared.
Luciferase assay
Wild-type sequences were obtained for NF-κB
(GGAATTCCCC) and AP-1 (TGAGTCA) DNA binding
sites. Reporter plasmids (pNF-κB-Luc and pAP-1-Luc)
were purchased from Stratagene (La Jolla, CA, USA).
The MMP-9-Luc plasmid was kindly provided by Dr.
C.K. Glass [34]. HepG2-HBx cell lines were co-
transfected with reporter plasmids, treated with DOX
for 20 h, and the luciferase activity determined. Briefly,
HepG2-HBx cells were washed with PBS and lysed with
50 μL passive lysis buffer (Promega, Madison, WI, USA)
at various time points after treatment. Lysates were
transferred to 96-well plates, and the substrate was
added (Promega, Madison, WI). A microplate reader
(Synergy HT, Bio-Tek, Winooski, VT, USA) was used to
assess the luciferase activity. Relative luciferase activity
was calculated by dividing the relative luciferase units of
MMP-9, NF-κB, or AP-1 reporter plasmid-transfected
cells by the relative luciferase units of pGL3-Basic–
transfected cells.
Preparation of nuclear extracts and electrophoretic
mobility shift assay (EMSA)
HepG2-HBx cells were treated with 100–800 μg/ml
SNS. Nuclear extracts were prepared as described pre-
viously [35]. In brief, cells were stimulated, harvested
by centrifugation, washed twice with cold PBS, and nu-
clear extracts prepared using the NE-PER reagent
(Pierce, Rockford, IL, USA) according to the manufac-
turer's instructions. Biotin-labeled complementary oligo-
nucleotides corresponding to NF-κB– and AP-1–binding
sites were annealed. Biotinylated electrophoretic mobility
shift assays (EMSAs) were performed as previously
described [36], and gels were transferred to nylon
membranes after electrophoresis. Membranes were
blocked in blocking solution and proteins detected using
alkaline phosphatase-conjugated streptavidin (Chemicon,
Australia) followed by chemiluminescence assay (Roche,
Germany).
Western blot analysis
HepG2-HBx cells treated with or without DOX and
100–800 μg/ml SNS were lysed in 250 μL of sample
buffer (62.5 mM Tris–HCl, 2 % SDS, 10 % glycerol,
50 mM dithiothreitol, and 0.1 % bromophenol blue;
pH 6.8). We also collected the supernatants from
cultures treated with SNS or 80 μM TPA. The superna-
tants were concentrated 40-fold using a Minicon filter
(Millipore, Billerica, MA, USA) with a 15-kDa– cutoff
pore diameter. Protein concentrations were determined
using the BCA Protein Assay Kit (Pierce, Rockford, IL,
USA). The cytoplasmic extracts (cytosol) were prepared
using the Cytoplasmic Extraction Reagent (Pierce) ac-
cording to the manufacturer's instructions. To assess
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the translocation of p65, the concentrations of p65
protein in cytoplasmic and nuclear extracts were de-
tected by Western blot analysis. Proteins (10 μg for cell
lysates and 40 μg for supernatants) were separated by
10 % SDS-polyacrylamide gel electrophoresis, and pro-
tein bands were transferred electrophoretically to
nitrocellulose membranes. Membranes were probed
with polyclonal antibodies against GFP, p65, MMP-9,
EGFR, Akt, PI3K, IκB-α, phosphorylated IκB-α, JNK,
phosphorylated JNK, p38, phosphorylated p38, ERK,
phosphorylated ERK, and β-actin (Cell Signaling
Technology, Beverly, MA, USA). Bound antibodies
were detected using peroxidase-conjugated anti-rabbit
antibodies followed by chemiluminescence assay (ECL
System; Amersham, Buckinghamshire, UK) and
autoradiography.
Statistical analysis
One-way analysis of variance (ANOVA) was used to iden-
tify significant differences between the means (p < 0.05). If
the means differed significantly, the Tukey-Kramer
post-hoc test was used to compare the groups. Data are
shown as the mean ± standard error of the mean
(SEM).
Fig. 1 Establishment of constitutive HBx expression in HepG2 cells. HepG2 cells were transfected with pRT-HBx-GFP. After selection of
G418-resistant colonies, cell proliferation with and without DOX treatment was assessed by MTT assay (a). HepG2-HBx-GFP cells with and
without DOX were observed with a fluorescence microscope (b). Expression of the HBx-GFP fusion protein in HepG2-HBx-GFP cells with
and without DOX treatment was determined by Western blot analysis using a GFP-specific antibody. β-actin was included as an internal
control (c)
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Results
HBx expression in HepG2 cells and Cell Viability
To determine whether HBx modulates the expression of
MMP-9, we first confirmed whether HBx and the HBx-
GFP fusion protein were expressed in HBx-transfected
cells treated with or without DOX. GFP-fusion-protein ex-
pression was monitored using fluorescence microscopy,
which detects fluorescence of the GFP protein (Fig. 1a).
Furthermore, western blot analysis using an anti-GFP
antibody showed HBx protein expression by transfectants
(HepG2-HBx-GFP) only in the presence of DOX (Fig. 1b).
In cells expressing GFP, fluorescence was observed in both
the nucleus and cytosol. We therefore concluded that
HBx-GFP was successfully transfected into HepG2 cells.
The cytotoxicity of HBx-GPF transfection and SNS
treatment was evaluated using the MTT assay. No
cytotoxic effects were observed for 100–800 μg/ml SNS
without DOX, but cell numbers were slightly increased
in those transfected with HBx-GPF in the presence of
DOX (Fig. 1c).
SNS inhibited HBx-induced invasion and migration in
HepG2 cells
In vitro invasion and migration assays were used to
determine the inhibitory effect of SNS on the invasive
potency of human hepatoma HepG2 cells. HBx transfec-
tion increased the invasiveness of HepG2 cells, which
was inhibited by SNS in a concentration-dependent
manner at 100, 200, 400 and 800 μg/ml (Fig. 2b, c).
HBx-induced migration of HepG2 cells was inhibited in
a concentration-dependent manner by treatment with
SNS at 200, 400 and 800 μg/ml (Fig. 2a). Taken together,
Fig. 2 Effect of SNS on HBx-induced migration and invasion. a For the wound healing assay, HepG2-HBx-GFP cells with or without DOX were treated
with different concentrations of SNS in 6-well plates and incubated for 24 h. Photomicrographs of the wounds were obtained under 100× magnification.
b HepG2-HBx-GFP cells (5 × 104) were resuspended in 200 μL of DMEM, added to the upper compartment of Matrigel invasion chambers, and treated
with or without DOX and different concentrations of SNS. After 24 h, the cells on the lower surface of the insert were stained with crystal violet and
counted under a microscope (200× magnification). c For cell quantification, HepG2 and HepG2-HBx-GFP cells were pre-treated with 100–800 μg/ml of
SNS for 24 h. Results are expressed as fold-invasion and presented as the total number of invasive cells in treated cells relative to that in untreated cells.
Values represent the mean ± SEM of 3 independent experiments. *p < 0.01 compared to HBx(DOX-treated) cells
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these data indicate that SNS inhibits HBx-induced cell
motility in vitro.
Effect of SNS on HBx-induced MMP-9 expression and
activity
Tumor invasion requires increased expression of MMP-
9. To study whether the gelatinolytic activity of MMP in
HepG2-HBx cells can be activated by HBx, we per-
formed zymographic analyses. Figure 3a shows that
treatment with DOX for 24 h significantly increased
MMP-9 expression in HepG2 cells. HBx-induced MMP-
9 expression was inhibited by 400 and 800 μg/ml SNS.
This inhibition resulted from increased MMP-9 in the
culture medium (supernatant) and cytosol (Fig. 3b, c).
Effect of SNS on HBx-activated transcription of MMP-9,
NF-κB, and AP-1 promoters
To determine whether the transcription of MMP-9, NF-
κB, and AP-1 is regulated by HBx, we examined the
promoter activity of these genes in HepG2-HBx cells co-
Fig. 3 Effect of SNS on HBx-induced MMP-9 expression and activity. a Conditioned medium was collected from cultures after 24 h and analyzed
by gelatin zymography. HepG2-HBx-GFP cells were cultured in 25 cm2 flasks, pretreated with 100–800 μg/ml of SNS for 1 h, then treated with
DOX for 16 h. b Western blot analyses showed MMP-9 secretion into the culture medium (supernatant) and MMP-9. HepG2-HBx-GFP cells were
pretreated with 100–800 μM SNS for 1 h, then treated with DOX for 16 h. Nuclear and cytosolic extracts were then prepared and subjected to
western blot analysis using antibodies specific for MMP-9 expression. c Values of MMP-9 expression in the cytosol represent the mean ± SEM of 3
independent experiments. *p < 0.01 compared to HBx-expressing cells
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Fig. 4 (See legend on next page.)
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transfected with pMMP-9, pNF-κB, or pAP-1 by lucifer-
ase assay. The MMP-9 promoter was activated by HBx
at levels approximately 3.6-fold greater than that of con-
trol MMP-9 promoter-transfected cells; this activation
was suppressed by SNS in a dose-dependent manner
and significantly suppressed by 400 and 800 μg/ml SNS
(Fig. 4a). The NF-κB promoter was activated approxi-
mately 3.7-fold over that of NF-κB–transfected cells in
response to HBx; this activation was suppressed by SNS
in a concentration-dependent manner and significantly
suppressed by 400 and 800 μg/ml SNS (Fig. 4b). Simi-
larly, the AP-1 promoter was activated approximately
4.1-fold over that of AP-1-transfected cells in response
to HBx; this activity was also suppressed by SNS in a
concentration-dependent manner and significantly sup-
pressed by 400 and 800 μg/ml SNS (Fig. 4c).
To determine whether the inhibitory effect of SNS in
HBx-treated cells leads to NF-κB and AP-1 inhibition,
the effects of SNS on HBx-stimulated NF-κB- and AP-1-
specific DNA binding activity were examined. Using bio-
tinylated EMSAs, HBx was shown to increase DNA
binding of NF-κB and AP-1 after 45 min. Treatment
with 400 and 800 μg/ml SNS inhibited HBx-induced
DNA binding by NF-κB and AP-1 (Fig. 5a, b).
Inhibitory effect of SNS on HBx-induced activation of
MAPKs, IκB, and PI3K/ AKT
MAPKs are known to regulate AP-1 and NF-κB activation
via multiple mechanisms. Studies have shown that the
MAPK, IκB, and PI3K/Akt signaling pathways are in-
volved in HBx-mediated induction of MMP-9 [9, 37–39].
Therefore, we investigated the effects of SNS on HBx-
induced phosphorylation of ERK, p38, JNK, IκB, and
PI3K/Akt activity in HepG2 cells. Western blot analysis
revealed that HBx expression alone caused a significant
increase in the phosphorylation of ERK, p38, JNK, IκB,
PI3K, and Akt compared to vehicle-treated controls; this
phosphorylation was blocked by pre-treatment with SNS
(Fig. 6). HBx-induced phosphorylation of MAPK, IκB, and
PI3K/Akt was inhibited in cells treated with 400 and
800 μg/ml SNS.
Discussion
Invasion and metastasis are fundamental properties of
malignant cancer cells. Traditional Chinese herbal medi-
cine could improve the prognosis and metastasis of can-
cer [40–43]. Metastasis of HCC is frequently observed,
even at the early stages of the disease, and appears to be
the main cause of shorten survival time of HCC patients
[44]. The activation of signaling pathways by HBx may
lead not only to the activation of transcription factors
but also to profound cytological changes that contribute
to tumor development, such as the acquisition of meta-
static properties [8]. Elevated plasma levels of MMP-9 in
patients with HCC have also been observed, especially in
patients with macroscopic portal vein invasion [45].
HBV-negative HepG2, a highly invasive human hepato-
cellular carcinoma cell line , expresses moderate levels
of MMP-9 [46]. HBx may induce MMP-9 expression
and invasiveness in HBx-transfected cells [9, 11]. We
hypothesize that SNS may suppress HBx-induced MMP-
9 expression through activation of AP-1 and NF-κB.
Thus, in this study, we investigated the effect of SNS on
MMP-9 expression, cell invasiveness, metastasis in HBx-
transfected cells, and the regulation of HBx–induced
MMP-9 via signal pathways in HBx-transfected HepG2
cells.
Recent research has revealed the pharmacological ac-
tions of Chaihu (ingredients of SNS). Chaihu and its active
components (saikosaponins) exhibited hepatoprotective
[47], and anticancer effects [48, 49]. Baishao (Paeoniae
radix) has been reported as a potential anticarcinogenesis
agent [50] and anticancer effect [51]. Zhishi (Fructus
Aurantii Immaturus) inhibited the translocation of NF-κB
p65 [52]. Hesperidin (50 μM) and naringenin (25 μM), the
major flavanones of Fructus aurantii [53], suppress TPA-
induced tumor metastasis and MMP-9 transcription by
inhibiting NF-κB and AP-1 activity [23, 54–56]. Several
studies have shown that MMP-9 expression is induced by
HBx playing an important role in cancer invasion and me-
tastasis in liver cells [9, 11, 37]. In the present study, we
have shown for the first time that SNS suppresses HBx-
induced cell invasiveness and MMP-9 expression, thereby
decreasing HCC migration and invasion.
Stimulators increase the expression of MMP-9 through
several signaling pathways, resulting in increased cell inva-
siveness. The promoter region of MMP-9 has both AP-1
and NF-κB binding sites. Stimulators, including cytokines,
control the expression of MMP-9 by modulating the acti-
vation of transcription factors such as AP-1 and NF-κB
through the Ras/Raf/ERK, JNK, and PI-3 K-AKT/PKB sig-
naling pathways [9, 14, 18, 19]. The HBx protein has been
shown to stimulate the activity of tPI-3 K-Akt/ PKB as
well as ERK 1/2 in HBx-transfected cells [9]. Another
(See figure on previous page.)
Fig. 4 Effect of SNS on HBx -induced MMP-9-, NF-κB-, and AP-1-dependent luciferase reporter gene expression. HepG2-HBx-GFP cells treated
with increasing concentrations of SNS were transfected with MMP-9- a, NF-κB- b, or AP-1 c-containing plasmids linked to the luciferase gene.
HepG2-HBx-GFP cells were pretreated with 100–800 μM SNS for 1 h, then treated with DOX for 16 h. After 16 h treated with DOX, cell lysates
were assayed for luciferase activity. Results are expressed as fold-activity over that of untreated transfected cells. Values represent the mean ±
SEM of 3 independent experiments. *p < 0.01 compared to HBx (DOX-treated) cells
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Fig. 5 Effect of SNS on TPA-induced NF-κB and AP-1 activation in HepG2 cell. EMSAs were performed on nuclear extracts following HBx-induced
NF-κB (a) and AP-1 (b) activation. HepG2-HBx-GFP cells were pretreated with 200–800 μg/ml SNS for 1 h, then treated with DOX for 45 min,
followed by nuclear extract preparation
Fig. 6 Effect of SNS on HBx-induced, MAPK, IκB, and AKT- signaling pathways. HepG2-HBx-GFP cells were pretreated with 200–800 μg/ml SNS
before incubation with DOX for 45 min. Whole-cell lysates were then prepared and subjected to Western blot analysis using antibodies specific
for phosphorylated PI3k, AKT, IκB, JNK, p38, and ERK in Western blot
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report showed that HBx transfection induced NF-κB acti-
vation in HepG2 cells through inhibition of nuclear
factor-κB kinase β (IKKβ) [57]. The present study showed
that SNS effectively suppressed HBx-induced MMP-9
gene expression by suppressing the MAPK/AP-1 and
PI3K/AKT/NF-κB cascades, with consequent suppression
of tumor migration and invasion by human hepatoma
HepG2 cells.
Conclusion
We provide evidence that SNS exerts an anti-invasive
and anti-migratory effect on HBx-activated hepatoma
cells via the downregulation of PI3K/AKT, decreasing
MAPK and IκB pathway signaling, NF-κB and AP-1 ac-
tivity, and MMP-9 expression. SNS thus may have the
therapeutic potential to inhibit the invasion and metasta-
sis of HCC.
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